1. Home
  2. KNSA vs ANDE Comparison

KNSA vs ANDE Comparison

Compare KNSA & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • ANDE
  • Stock Information
  • Founded
  • KNSA 2015
  • ANDE 1947
  • Country
  • KNSA United Kingdom
  • ANDE United States
  • Employees
  • KNSA N/A
  • ANDE N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • ANDE Farming/Seeds/Milling
  • Sector
  • KNSA Health Care
  • ANDE Industrials
  • Exchange
  • KNSA Nasdaq
  • ANDE Nasdaq
  • Market Cap
  • KNSA 1.5B
  • ANDE 1.3B
  • IPO Year
  • KNSA 2018
  • ANDE N/A
  • Fundamental
  • Price
  • KNSA $20.21
  • ANDE $38.12
  • Analyst Decision
  • KNSA Strong Buy
  • ANDE Buy
  • Analyst Count
  • KNSA 6
  • ANDE 1
  • Target Price
  • KNSA $37.17
  • ANDE $55.00
  • AVG Volume (30 Days)
  • KNSA 638.0K
  • ANDE 470.6K
  • Earning Date
  • KNSA 04-29-2025
  • ANDE 05-06-2025
  • Dividend Yield
  • KNSA N/A
  • ANDE 2.05%
  • EPS Growth
  • KNSA N/A
  • ANDE 12.93
  • EPS
  • KNSA N/A
  • ANDE 3.32
  • Revenue
  • KNSA $423,239,000.00
  • ANDE $11,257,548,000.00
  • Revenue This Year
  • KNSA $37.21
  • ANDE $5.97
  • Revenue Next Year
  • KNSA $2.58
  • ANDE $4.31
  • P/E Ratio
  • KNSA N/A
  • ANDE $11.48
  • Revenue Growth
  • KNSA 56.60
  • ANDE N/A
  • 52 Week Low
  • KNSA $16.56
  • ANDE $35.88
  • 52 Week High
  • KNSA $28.15
  • ANDE $61.46
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 44.56
  • ANDE 40.78
  • Support Level
  • KNSA $18.26
  • ANDE $37.26
  • Resistance Level
  • KNSA $21.24
  • ANDE $38.80
  • Average True Range (ATR)
  • KNSA 1.12
  • ANDE 1.86
  • MACD
  • KNSA -0.12
  • ANDE -0.25
  • Stochastic Oscillator
  • KNSA 44.43
  • ANDE 28.83

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

Share on Social Networks: